Acetylation of BLM protein regulates its function in response to DNA damage

Bloom syndrome is an autosomal recessive disease with phenotypes of cancer predisposition and premature aging caused by mutations of the blm gene. BLM belongs to the RecQ DNA helicase family and functions in maintaining genomic stability. In this study, we found that several lysine residues of BLM w...

Full description

Saved in:
Bibliographic Details
Published inRSC advances Vol. 7; no. 87; pp. 5531 - 5538
Main Authors Wang, Yankun, Luo, Jianyuan
Format Journal Article
LanguageEnglish
Published Cambridge Royal Society of Chemistry 01.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bloom syndrome is an autosomal recessive disease with phenotypes of cancer predisposition and premature aging caused by mutations of the blm gene. BLM belongs to the RecQ DNA helicase family and functions in maintaining genomic stability. In this study, we found that several lysine residues of BLM were acetylated in cells. The dynamic acetylation levels of BLM were regulated by CBP/p300 and SIRT1. We further identified that five lysines, K476, K863, K1010, K1329, and K1411, are the major acetylation sites. Treating cells with different DNA damage agents found that acetylation of BLM was different in response to etoposide and hydroxyurea, suggesting that BLM acetylation may have multiple functions in DNA repair. This study first revealed the acetylation of the BLM protein and studied this regulatory process in the DNA damage response.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2046-2069
2046-2069
DOI:10.1039/c7ra06666j